Latest News
Unlicensed Cannabis-Based Products for Medicinal (CBPM) Use
On the 16th of November 2022 the Medicines and Healthcare products Regulatory Agency (MHRA) released a blog with guidance on the process for approving Manufacturing Authorisations/ API Registrations in relation to unlicensed Cannabis-Based Products for Medicinal (CBPM) use.
NIMAR – The list is getting longer…
The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market
The value of proper Export training – be prepared!
Many clients contact us for information and help on expanding the scope of their WDA license to include the ability to export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.